CEBPA-dependent HK3 and KLF5 Expression in Primary AML and During AML Differentiation

Scientific Reports - United Kingdom
doi 10.1038/srep04261
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

AML Cells Block HSC Differentiation

Cancer Discovery
Oncology
2013English

Heterogeneity Within AML With CEBPA Mutations; Only CEBPA Double Mutations, but Not Single CEBPA Mutations Are Associated With Favourable Prognosis

British Journal of Cancer
Cancer ResearchOncology
2009English

The Tumour-Suppressive miR-29a/b1 Cluster Is Regulated by CEBPA and Blocked in Human AML

British Journal of Cancer
Cancer ResearchOncology
2010English

In Vitro Transformation of Primary Human CD34+ Cells by AML Fusion Oncogenes: Early Gene Expression Profiling Reveals Possible Drug Target in AML

PLoS ONE
Multidisciplinary
2010English

Dasatinib Promotes ATRA-induced Differentiation of AML Cells

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2009English

Genetic Deletions in AML and MDS

Best Practice and Research in Clinical Haematology
OncologyClinical Biochemistry
2010English

The Clinical Relevance of BAALC and ERG Expression Levels in Pediatric AML

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2012English

Aberrant Splicing and Drug Resistance in AML

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2016English

Clinical Significance Ofin Vivocytarabine-Induced Gene Expression Signature in AML

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy